Funding is requested to support studies on the structure and function of the membrane glycoprotein (GP) Ib-IX-V complex, a platelet receptor that binds von Willebrand factor (vWF) and a-thrombin. This proposal consists of four specific aims. 1) Analysis of interactions induced by exogenous modulators under static conditions indicates that the residues involved in vWF binding are located in the 45 kDa amino terminal domain of GP Iba. To obtain information related to events in flowing blood, fluorescent beads will be coated with recombinant 45 kDa fragment as a mimic of the receptor on platelets. The interaction with vWF will be studied under flow, and selected mutations will be expressed to define amino acid residues relevant to function. 2) Platelets have unique properties that cannot be mimicked by other cells, notably the capacity to undergo homotypic aggregation forming thrombi in rapidly flowing blood. Human GP Iba will be expressed in mouse platelets deficient in the endogenous homologue, thus obtaining membrane GP Ib-IX-V amenable to mutagenesis in the GP Iba subunit. The information database on the human receptor will be used to introduce selected structural modifications in GP Iba and define the functional consequences on vWF-dependent platelet adhesion and aggregation in flowing blood. Moreover, specific mutations in the intracytoplasmic domains of the protein will be evaluated with respect to the consequences on the interaction with vWF and the generation of outside-in signals important for platelet activation. 3) Activation of human platelets by a-thrombin involves the protease-activated receptor (PAR) 1 with the possible contribution of the homologous PAR-4. The significance of a-thrombin binding to GP Iba is still debated. We will obtain mouse platelets expressing the human a-subunit in the GP Ib-IX-V complex, and generate mutants lacking a-thrombin but not vWF binding. We will use this approach to modulate a-thrombin binding to GP Iba and define the consequences on platelet activation and function. 4) The p-subunit of GP Ib is important for assembly of the GP Ib-IX-V complex. Moreover, biochemical studies suggest the GP Ibp may participate in platelet signaling, thus contributing directly to the adhesive properties of GP Ib-IX-V. A mouse model lacking active GP Ibp will be generated to address the in vivo relevance of its putative signaling function. The results obtained with the proposed studies will enhance our understanding of biological processes intimately involved with hemostasis and arterial thrombosis, likely benefiting patients through better prevention, diagnosis and treatment of atherosclerotic cardiovascular disease.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Program Officer
Link, Rebecca P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Moccetti, Federico; Brown, Eran; Xie, Aris et al. (2018) Myocardial Infarction Produces Sustained Proinflammatory Endothelial Activation in Remote Arteries. J Am Coll Cardiol 72:1015-1026
Shim, Chi Young; Liu, Ya Ni; Atkinson, Tamara et al. (2015) Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis. Circ Cardiovasc Imaging 8:e002765
Kaplan, Zane S; Zarpellon, Alessandro; Alwis, Imala et al. (2015) Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4. Nat Commun 6:7835
Guidotti, Luca G; Inverso, Donato; Sironi, Laura et al. (2015) Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell 161:486-500
Koltsova, E K; Sundd, P; Zarpellon, A et al. (2014) Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis. Thromb Haemost 112:1252-63
Yokota, N; Zarpellon, A; Chakrabarty, S et al. (2014) Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice. J Thromb Haemost 12:71-81
Baccala, Roberto; Welch, Megan J; Gonzalez-Quintial, Rosana et al. (2014) Type I interferon is a therapeutic target for virus-induced lethal vascular damage. Proc Natl Acad Sci U S A 111:8925-30
Doshi, Nishit; Orje, Jennifer N; Molins, Blanca et al. (2012) Platelet mimetic particles for targeting thrombi in flowing blood. Adv Mater 24:3864-9
Li, Conglei; Piran, Siavash; Chen, Pingguo et al. (2011) The maternal immune response to fetal platelet GPIb* causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest 121:4537-47
Zarpellon, Alessandro; Celikel, Reha; Roberts, James R et al. (2011) Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I. Proc Natl Acad Sci U S A 108:8628-33

Showing the most recent 10 out of 77 publications